An integrative framework to prioritize genes in more than 500 loci associated with body mass index

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

An integrative framework to prioritize genes in more than 500 loci associated with body mass index. / Hemerich, Daiane; Svenstrup, Victor; Obrero, Virginia Diez; Preuss, Michael H.; Moscati, Arden; Hirschhorn, Joel N; Loos, Ruth J F.

I: American Journal of Human Genetics, Bind 6, Nr. 6, 2024, s. 1035-1046.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Hemerich, D, Svenstrup, V, Obrero, VD, Preuss, MH, Moscati, A, Hirschhorn, JN & Loos, RJF 2024, 'An integrative framework to prioritize genes in more than 500 loci associated with body mass index', American Journal of Human Genetics, bind 6, nr. 6, s. 1035-1046. https://doi.org/10.1016/j.ajhg.2024.04.016

APA

Hemerich, D., Svenstrup, V., Obrero, V. D., Preuss, M. H., Moscati, A., Hirschhorn, J. N., & Loos, R. J. F. (2024). An integrative framework to prioritize genes in more than 500 loci associated with body mass index. American Journal of Human Genetics, 6(6), 1035-1046. https://doi.org/10.1016/j.ajhg.2024.04.016

Vancouver

Hemerich D, Svenstrup V, Obrero VD, Preuss MH, Moscati A, Hirschhorn JN o.a. An integrative framework to prioritize genes in more than 500 loci associated with body mass index. American Journal of Human Genetics. 2024;6(6):1035-1046. https://doi.org/10.1016/j.ajhg.2024.04.016

Author

Hemerich, Daiane ; Svenstrup, Victor ; Obrero, Virginia Diez ; Preuss, Michael H. ; Moscati, Arden ; Hirschhorn, Joel N ; Loos, Ruth J F. / An integrative framework to prioritize genes in more than 500 loci associated with body mass index. I: American Journal of Human Genetics. 2024 ; Bind 6, Nr. 6. s. 1035-1046.

Bibtex

@article{88089cf0262442e4b9c8a0e12c7286ef,
title = "An integrative framework to prioritize genes in more than 500 loci associated with body mass index",
abstract = "Obesity is a major risk factor for a myriad of diseases, affecting >600 million people worldwide. Genome-wide association studies (GWASs) have identified hundreds of genetic variants that influence body mass index (BMI), a commonly used metric to assess obesity risk. Most variants are non-coding and likely act through regulating genes nearby. Here, we apply multiple computational methods to prioritize the likely causal gene(s) within each of the 536 previously reported GWAS-identified BMI-associated loci. We performed summary-data-based Mendelian randomization (SMR), FINEMAP, DEPICT, MAGMA, transcriptome-wide association studies (TWASs), mutation significance cutoff (MSC), polygenic priority score (PoPS), and the nearest gene strategy. Results of each method were weighted based on their success in identifying genes known to be implicated in obesity, ranking all prioritized genes according to a confidence score (minimum: 0; max: 28). We identified 292 high-scoring genes (≥11) in 264 loci, including genes known to play a role in body weight regulation (e.g., DGKI, ANKRD26, MC4R, LEPR, BDNF, GIPR, AKT3, KAT8, MTOR) and genes related to comorbidities (e.g., FGFR1, ISL1, TFAP2B, PARK2, TCF7L2, GSK3B). For most of the high-scoring genes, however, we found limited or no evidence for a role in obesity, including the top-scoring gene BPTF. Many of the top-scoring genes seem to act through a neuronal regulation of body weight, whereas others affect peripheral pathways, including circadian rhythm, insulin secretion, and glucose and carbohydrate homeostasis. The characterization of these likely causal genes can increase our understanding of the underlying biology and offer avenues to develop therapeutics for weight loss.",
author = "Daiane Hemerich and Victor Svenstrup and Obrero, {Virginia Diez} and Preuss, {Michael H.} and Arden Moscati and Hirschhorn, {Joel N} and Loos, {Ruth J F}",
note = "Copyright {\textcopyright} 2024 The Author(s). Published by Elsevier Inc. All rights reserved.",
year = "2024",
doi = "10.1016/j.ajhg.2024.04.016",
language = "English",
volume = "6",
pages = "1035--1046",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "6",

}

RIS

TY - JOUR

T1 - An integrative framework to prioritize genes in more than 500 loci associated with body mass index

AU - Hemerich, Daiane

AU - Svenstrup, Victor

AU - Obrero, Virginia Diez

AU - Preuss, Michael H.

AU - Moscati, Arden

AU - Hirschhorn, Joel N

AU - Loos, Ruth J F

N1 - Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

PY - 2024

Y1 - 2024

N2 - Obesity is a major risk factor for a myriad of diseases, affecting >600 million people worldwide. Genome-wide association studies (GWASs) have identified hundreds of genetic variants that influence body mass index (BMI), a commonly used metric to assess obesity risk. Most variants are non-coding and likely act through regulating genes nearby. Here, we apply multiple computational methods to prioritize the likely causal gene(s) within each of the 536 previously reported GWAS-identified BMI-associated loci. We performed summary-data-based Mendelian randomization (SMR), FINEMAP, DEPICT, MAGMA, transcriptome-wide association studies (TWASs), mutation significance cutoff (MSC), polygenic priority score (PoPS), and the nearest gene strategy. Results of each method were weighted based on their success in identifying genes known to be implicated in obesity, ranking all prioritized genes according to a confidence score (minimum: 0; max: 28). We identified 292 high-scoring genes (≥11) in 264 loci, including genes known to play a role in body weight regulation (e.g., DGKI, ANKRD26, MC4R, LEPR, BDNF, GIPR, AKT3, KAT8, MTOR) and genes related to comorbidities (e.g., FGFR1, ISL1, TFAP2B, PARK2, TCF7L2, GSK3B). For most of the high-scoring genes, however, we found limited or no evidence for a role in obesity, including the top-scoring gene BPTF. Many of the top-scoring genes seem to act through a neuronal regulation of body weight, whereas others affect peripheral pathways, including circadian rhythm, insulin secretion, and glucose and carbohydrate homeostasis. The characterization of these likely causal genes can increase our understanding of the underlying biology and offer avenues to develop therapeutics for weight loss.

AB - Obesity is a major risk factor for a myriad of diseases, affecting >600 million people worldwide. Genome-wide association studies (GWASs) have identified hundreds of genetic variants that influence body mass index (BMI), a commonly used metric to assess obesity risk. Most variants are non-coding and likely act through regulating genes nearby. Here, we apply multiple computational methods to prioritize the likely causal gene(s) within each of the 536 previously reported GWAS-identified BMI-associated loci. We performed summary-data-based Mendelian randomization (SMR), FINEMAP, DEPICT, MAGMA, transcriptome-wide association studies (TWASs), mutation significance cutoff (MSC), polygenic priority score (PoPS), and the nearest gene strategy. Results of each method were weighted based on their success in identifying genes known to be implicated in obesity, ranking all prioritized genes according to a confidence score (minimum: 0; max: 28). We identified 292 high-scoring genes (≥11) in 264 loci, including genes known to play a role in body weight regulation (e.g., DGKI, ANKRD26, MC4R, LEPR, BDNF, GIPR, AKT3, KAT8, MTOR) and genes related to comorbidities (e.g., FGFR1, ISL1, TFAP2B, PARK2, TCF7L2, GSK3B). For most of the high-scoring genes, however, we found limited or no evidence for a role in obesity, including the top-scoring gene BPTF. Many of the top-scoring genes seem to act through a neuronal regulation of body weight, whereas others affect peripheral pathways, including circadian rhythm, insulin secretion, and glucose and carbohydrate homeostasis. The characterization of these likely causal genes can increase our understanding of the underlying biology and offer avenues to develop therapeutics for weight loss.

U2 - 10.1016/j.ajhg.2024.04.016

DO - 10.1016/j.ajhg.2024.04.016

M3 - Journal article

C2 - 38754426

VL - 6

SP - 1035

EP - 1046

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 6

ER -

ID: 392443847